Ivey Business School (Canada)
-
Sirona Hygiene Private Limited: Branding in an Intimate Hygiene Space - Teaching Note
Rituparna Basu; Neena SondhiTeaching Note IVEY-8B21A002-EMarketingTeaching note for product 9B21A002.Starting at €0.00
-
Embrace (B): Opportunity Assessment
Mridula Anand; Anand Nandkumar; Charles DhanarajCase IVEY-9B13M005-EEntrepreneurship, StrategyAWARD WINNING CASE - Indian Management Issues and Opportunities Award, 2013 European Foundation for Management Development (EFMD) Case Writing Competition. Part B of a four-part series, which also includes 9B13M004, 9B13M006 and 9B13M007.Starting at €5.74
-
Embrace (C): Competing with Incumbents
Mridula Anand; Anand Nandkumar; Charles DhanarajCase IVEY-9B13M006-EEntrepreneurship, StrategyAWARD WINNING CASE - Indian Management Issues and Opportunities Award, 2013 European Foundation for Management Development (EFMD) Case Writing Competition. Part C of a four-part series, which also includes 9B13M004, 9B13M005 and 9B13M007.Starting at €5.74
-
Clubb International: Revisiting the Marketing Strategy - Teaching Note
Neena Sondhi; Rituparna BasuTeaching Note IVEY-8B18A009-EMarketingTeaching note for product 9B18A009.Starting at €0.00
-
Nappa Dori: Crafting the Branding Strategy - Teaching Note
Neena Sondhi; Rituparna BasuTeaching Note IVEY-8B19A043-EMarketingTeaching note for product 9B19A043.Starting at €0.00
-
Eli Lilly in India: Rethinking the Joint Venture Strategy (Spanish version)
Charles Dhanaraj; Paul W. Beamish; Nikhil CellyCase IVEY-9B04MS16StrategyEli Lilly and Company es una compañía líder en farmacéutica de Los Estados Unidos. El nuevo Presidente de operaciones intercontinentales es reevaluando todas las divisiones de la empresa, incluyendo la empresa conjunta con Ranbaxy Laboratories Limited, una de las empresas farmacéuticas más grandes de la India. Esta estrategia conjunta ha funcionado sin problemas durante varios años a pesar de sus diferencias de enfoque, pero recientemente Ranbaxy...Starting at €8.20
-
Oral Insulin: Breakthrough Innovation at Biocon
Nita Sachan; Prasad Kaipa; Anand Nandkumar; Charles DhanarajCase IVEY-9B11M065-EEntrepreneurship, Service and Operations Management, StrategyThis case deals with the innovation challenges of a medium-sized firm (under $1 billion) in an emerging economy (India), particularly the challenges of product development and commercialization. The management has to decide how to proceed with a promising novel formula for oral insulin — promising both in terms of financial returns as well as social impact. The company has spent several years of research and development in getting the drug throug...Starting at €8.20
-
Cumi India's Global Strategy: The China Puzzle
S. Ramnarayan; Charles Dhanaraj; Krithiga SankaranCase IVEY-9B13M023-ELeadership and People Management, StrategyCarborundum Universal Murugappa International (CUMI) was a leading abrasives manufacturing company based in India with global operations in Russia, South Africa and China. In the global abrasives business, China held 50 per cent of the raw materials for the industry. China was also the largest market for abrasives worldwide and was expected to contribute to one third of the global demand for abrasives. CUMI had the vision to become a global leade...Starting at €8.20
-
A Student's Dilemma: Rent or Buy
Mehmet A. Begen; Caitlin Neal; Sabriya KarimCase IVEY-9B14E013-EInformation TechnologiesWhenever an investment is made, there are always costs and benefits. This case set in 2013 explores, based on quantitative and qualitative factors, a decision that a typical student at university might face. The decision to rent a house or purchase one in order to rent out the additional rooms is a difficult one. All of the pros and cons of each option need to be carefully considered. An Excel spreadsheet is available for students (see 7B14E013).Starting at €8.20
-
Seoul National Bank: The Chief Credit Officer’s Dilemma
Mehmet A. Begen; Jon JhunCase IVEY-9B11E013-ECorporate Governance, StrategyThe chief credit officer (CCO) at Seoul National Bank has recently faced numerous defaults on its corporate loans. To address this problem, the CCO must re-evaluate how the bank responds to defaults and determine a default strategy. The CCO must evaluate the payouts and risk profiles of 1) collecting on collateral, 2) partially settling, and 3) waiting and seeing. Further, the CCO must determine a systematic way to approve loans from companies. A...Starting at €8.20